Market Overview

Benzinga's Top Upgrades

Share:
Related MYL
RBC Says Stay Away From Mylan, Perrigo; Go Long Teva, Allergan
Mylan Receives Unconditional Clearance from EC on Acquisition of Perrigo
Teva to Buy Allergan's Generics Business for $40.5B - Analyst Blog (Zacks)
Related SHLM
Mid-Afternoon Market Update: A Schulman Slips After Q3 Results; Plug Power Shares Spike Higher
Mid-Day Market Update: Dow Tumbles 150 Points; Advanced Micro Devices Shares Slide On Nasty Guidance
InsiderInsights.com Daily Round Up 7/28/15: Horsehead Holding, Saga Communications, Unifi, Global Power Equipment (Seeking Alpha)

Analysts at Canaccord upgraded Mylan (NASDAQ: MYL) from “hold” to “buy.” Mylan's shares closed at $25.00 yesterday. Mylan's trailing-twelve-month ROE is 15.70%.

Analysts at Longbow upgraded A. Schulman (NASDAQ: SHLM) from “underperform” to “neutral.” A. Schulman's shares closed at $25.14 yesterday. A. Schulman's PEG ratio is 0.79.

Analysts at Benchmark upgraded Expedia (NASDAQ: EXPE) from “hold” to “buy.” Expedia's stock closed at $51.25 yesterday. Expedia's trailing-twelve-month operating margin is 14.22%.

Analysts at RBC Capital upgraded PulteGroup (NYSE: PHM) from “sector perform” to “outperform.” PulteGroup's shares closed at $17.01 yesterday. PulteGroup's trailing-twelve-month revenue is $4.35 billion.

Latest Ratings for MYL

DateFirmActionFromTo
Jul 2015Cowen & CompanyDowngradesOutperformMarket Perform
Jun 2015BTIG ResearchInitiates Coverage onBuy
Jun 2015CitigroupMaintainsNeutral

View More Analyst Ratings for MYL
View the Latest Analyst Ratings

Posted-In: top upgradesUpgrades Analyst Ratings

 

Related Articles (EXPE + MYL)

Get Benzinga's Newsletters